ARMP

Armata Pharmaceuticals, Inc.

2.97 USD
-0.03 (-1.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Armata Pharmaceuticals, Inc. stock is down -27.38% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 29 February’s closed higher than January.

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PS03 for pneumonia.